Literature DB >> 21567225

Eumycetoma of the hand caused by Leptosphaeria tompkinsii and refractory to medical therapy with voriconazole.

Katharine E Cartwright1, Tristan W Clark, Abid M Hussain, Martin Wiselka, Andrew Borman, Elizabeth M Johnson.   

Abstract

We report on the first case of eumycetoma caused by the organism Leptosphaeria tompkinsii to be diagnosed and possibly acquired within the United Kingdom. Conventional culture of fungal grains and surgical tissue specimens was negative and the diagnosis was achieved using panfungal polymerase chain reaction and sequencing technology. Despite limited surgical resection and prolonged antifungal therapy with voriconazole, the patient developed progressive disease with mycetoma bone involvement. This case highlights the usefulness of molecular diagnostic techniques in eumycetoma where organisms may fail to grow with conventional culture or be difficult to identify morphologically. It also reminds us that eumycetoma is a difficult infection to treat and despite optimism regarding the efficacy of the newer triazole antifungals in this condition, treatment failures may still occur.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21567225     DOI: 10.1007/s11046-011-9432-8

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  25 in total

1.  Madurella mycetomatis mycetoma treated successfully with oral voriconazole.

Authors:  C Lacroix; E de Kerviler; P Morel; F Derouin; M Feuilhade de Chavin
Journal:  Br J Dermatol       Date:  2005-05       Impact factor: 9.302

2.  Isolation, identification and susceptibility of Pyrenochaeta romeroi in a case of eumycetoma of the foot in the UK.

Authors:  Dasa Cerar; Yassen M Malallah; Susan J Howard; Paul Bowyer; David W Denning
Journal:  Int J Antimicrob Agents       Date:  2009-09-23       Impact factor: 5.283

3.  Polycytella hominis is a mutated form of Scedosporium apiospermum.

Authors:  Andrew M Borman; Colin K Campbell; Christopher J Linton; Paul D Bridge; Elizabeth M Johnson
Journal:  Med Mycol       Date:  2006-02       Impact factor: 4.076

4.  Molecular identification of black-grain mycetoma agents.

Authors:  Marie Desnos-Ollivier; Stéphane Bretagne; Françoise Dromer; Olivier Lortholary; Eric Dannaoui
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

5.  [Mycetoma: 130 cases].

Authors:  M-T Dieng; M-H Sy; B-M Diop; S-O Niang; B Ndiaye
Journal:  Ann Dermatol Venereol       Date:  2003-01       Impact factor: 0.777

Review 6.  Mycetoma caused by Madurella mycetomatis: a neglected infectious burden.

Authors:  Abdalla O A Ahmed; Willem van Leeuwen; Ahmed Fahal; Wendy van de Sande; Henri Verbrugh; Alex van Belkum
Journal:  Lancet Infect Dis       Date:  2004-09       Impact factor: 25.071

Review 7.  Emerging therapeutic regimes for the management of mycetomas.

Authors:  Mahreen Ameen; Roberto Arenas
Journal:  Expert Opin Pharmacother       Date:  2008-08       Impact factor: 3.889

8.  Laboratory and clinical assessment of ketoconazole in deep-seated mycoses.

Authors:  E Drouhet; B Dupont
Journal:  Am J Med       Date:  1983-01-24       Impact factor: 4.965

Review 9.  Management of mycetoma: major challenge in tropical mycoses with limited international recognition.

Authors:  Abdalla A O Ahmed; Wendy W J van de Sande; Ahmed Fahal; Irma Bakker-Woudenberg; Henri Verbrugh; Alex van Belkum
Journal:  Curr Opin Infect Dis       Date:  2007-04       Impact factor: 4.915

10.  Mycetoma in Yemen: clinicoepidemiologic and histopathologic study.

Authors:  Mishri Lal Khatri; Hussein Mohammed Al-Halali; Mohammed Fouad Khalid; Sultan Ahmed Saif; Mehesh Chandra R Vyas
Journal:  Int J Dermatol       Date:  2002-09       Impact factor: 2.736

View more
  1 in total

Review 1.  Hand Mycetoma: The Mycetoma Research Centre Experience and Literature Review.

Authors:  Rowa Fathelrahman Omer; Nancy Seif El Din; Fadwa Awad Abdel Rahim; Ahmed Hassan Fahal
Journal:  PLoS Negl Trop Dis       Date:  2016-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.